Skip to main content

Table 2 Gynecological and medical characteristics of the study participants, N = 361

From: Bacterial isolates and antibiotic susceptibility among women with abnormal vaginal discharge attending the gynecology clinic at a tertiary hospital in southwestern Uganda: a cross-sectional study

Variable

n (%)

Bacteria Isolated

P value

Yes, N = 107 n (%)

No, N = 254 n (%)

Prior infertility treatment

  

0.199

 Yes

14 (3.9)

2 (1.87)

12 (4.72)

 No

347(96.1)

105 (98.13)

242 (95.28)

Barrier FP method (condoms) n = 112

  

0.235

 Yes

8 (2.2)

4 (11.43)

4 (5.19)

 No

104 (28.8)

31(88.57)

73 (94.81)

Miscarriage in prior 6 weeks

  

0.598

 Yes

13 (3.6)

3 (2.80)

10 (3.94)

 No

348 (96.4)

104 (97.20)

244 (96.06)

Prior abnormal vaginal discharge

  

0.479

 Yes

259 (71.7)

74 (69.16)

185 (72.83)

 No

102 (28.3)

33 (30.84)

69 (27.17)

AVD times in last 6 months

  

0.324

 None

102 (28.3)

33 (30.84)

69 (27.17)

 Once

137 (38.0)

44 (41.12)

93 (36.61)

 >  = two times

122 (33.8)

30 (28.04)

92 (36.22)

Duration of current abnormal discharge

  

0.02

 ≤ 7 days

161 (44.6)

45 (42.06)

116 (45.67)

 8–14 days

104 (28.8)

41 (38.32)

63 (24.8)

 More than 14 days

96 (26.6)

21 (19.63)

75 (29.53)

Prior antibiotic use

   

0.705

 Yes

93 (25.8)

29 (27.1)

64 (25.2)

 No

268 (74.2)

78 (72.9)

190 (74.8)

Long term druga use

   

0.499

 Yes

109 (30.2)

35 (32.71)

74 (29.13)

 No

252 (69.8)

72 (67.29)

180 (70.87)

  1. FP Family Planning, AVD Abnormal Vaginal Discharge
  2. a Refers to use of antihypertensive or hypoglycemic drugs